| 4AZ2 | date | ![]() |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| authors | |||||||||||||||
| compound | source | ||||||||||||||
| symmetry |
| ||||||||||||||
| crystal cell |
| ||||||||||||||
| method | X-Ray Diffraction | resolution | |||||||||||||
| ligand | 9MU, NAG | enzyme |
| ||||||||||||
| Gene Ontology |
| ||||||||||||||
| Primary reference | Design and synthesis of potent and highly selective thrombin inhibitors., Hilpert K, Ackermann J, Banner DW, Gast A, Gubernator K, Hadvary P, Labler L, Muller K, Schmid G, Tschopp TB, et al., J Med Chem. 1994 Nov 11;37(23):3889-901. PMID:7966150 | ||||||||||||||
| Data retrieval |
![]() |
| View 4AZ2 in 3D |
Proteopedia, because life has more than 2D. |
| Structure-derived information |
| Sequence-derived information |
|
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |